Hutchens & Kramer Investment Management Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
HGIM
DC
CF
MIHAS
MR
Hutchens & Kramer Investment Management Group's ELV Position: Q2 2026 in Review
Hutchens & Kramer Investment Management Group reduced its Elevance Health (ELV) stake by 42% in Q2 2026, selling an estimated $220K and leaving 806 shares worth $312K. The position accounts for 0.08% of the portfolio, ranked #116.
Hutchens & Kramer Investment Management Group first reported a position in ELV in Q4 2022 and has held it in 12 quarters since. The position peaked at $661K in Q2 2025. 418 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Hutchens & Kramer Investment Management Group held 806 shares of Elevance Health worth $312K as of Q2 2026.
- Hutchens & Kramer Investment Management Group sold 592 Elevance Health shares in Q2 2026, an estimated $220K.
- Elevance Health made up 0.08% of Hutchens & Kramer Investment Management Group's portfolio in Q2 2026, its #116 holding.
- Hutchens & Kramer Investment Management Group first reported a position in Elevance Health in Q4 2022 and has held it in 12 quarters since.
- Hutchens & Kramer Investment Management Group's Elevance Health position peaked at $661K in Q2 2025.
- 418 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Hutchens & Kramer Investment Management Group's 13F filing for Q2 2026, filed 9 Jul 2026.